India: Gene silencing: (Spicy IP), India: US Patent reform implications for Indian Pharma: (Spicy IP), India: Generic pharmaceutical industry in the spotlight: (International Law Office), India: Supreme Court refuses to stay a Gujarat High Court decision restraining Ranbaxy from airing its controversial ads directed against Paras Pharma's 'Moov' brand: (Spicy IP),India: Patents on ARV drugs could increase costs: (Generic Pharmaceuticals & IP),US: Survey shows most… [read post]

In addition to the general full list, it includes additional tabs that include only the following subsets: Most Common Applicant: Sorts the list by the amount of applications filed by each applicant; Most Common Strings: List of gTLD strings with at least 2 separate applications; Unique Strings: you get the idea; Community; Geographic; Non-Standard Script: Applications for strings using other character sets; Notable Collisions: hand-picked, subjective, non-exhaustive list of conflicts over… [read post]